Browse All

Current Filters

CLEAR FILTER x

TITLE

Impact of Concomitant Therapy with a Dopamine Agonist on Converting Parkinson’s Disease Patients from Immediate-release Carbidopa-levodopa to CREXONT®

Author:Pahwa, Rajesh   Patel, Neepa   Falconer, Ramsey   Allard, Simon   Banisadr, Ghazal   Fisher, Stanley   

Session Name:P7: Movement Disorders: Parkinson's Disease Management  

Topic:Movement Disorders  

Program Number:P7.024  

Author Institution:University of Kansas Medical Center, Kansas City, KS  Rush University Medical Center, Chicago, IL  Inova Parkinson's & Movement Disorders Center, Alexandria, VA  Amneal Pharmaceuticals, Baltimore, MD  Amneal Pharmaceuticals, Evanston, IL  Amneal Pharmaceuticals, Warren, NJ  

Long-term Follow-up of Opicapone Use as Add-on to Levodopa in Parkinson’s Patients Without Motor Fluctuations: Findings from the EPSILON Study

Author:Ferreira, Joaquim   Rascol, Olivier   Stocchi, Fabrizio   Antonini, Angelo   Lapuente, Paloma   Castilla-Fernández, Guillermo   Brigas, Helena   Banisadr, Ghazal   Rocha, José-Francisco   Holenz, Joerg   Poewe, Werner   

Session Name:P7: Movement Disorders: Parkinson's Disease Management  

Topic:Movement Disorders  

Program Number:P7.027  

Author Institution:IMM Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa  CNS-Campus Neurológico, Instituto De Medicin, Portugal  Clinical Investigation Centre CIC1436 Departments of Neurosciences and Clinical Pharmacology, Centre of Excellence for Neurodegeneration COEN NeuroToul, and NS-Park/FCRIN network  University of Toulouse 3, University Hospital of Toulouse, INSERM, Toulouse, France  University San Raffaele Roma and Institute for Research and Medical Care IRCCS, Rome, Italy  BIAL – Portela & Ca S.A., CORONADO (S. Romão E S. Mamede, Portugal  Amneal Pharmaceuticals, Evanston, IL  Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria  

Conversion to CREXONT® in the RISE-PD Phase 3 Trial Improved Aspects of Sleep as Measured by the Parkinson’s Disease Sleep Scale-2 (PDSS-2)

Author:Ondo, William   Hauser, Robert   Grieb, Zachary   Banisadr, Ghazal   Fisher, Stanley   

Session Name:P11: Movement Disorders: Therapeutics in Study for Parkinson's Disease  

Topic:Movement Disorders  

Program Number:P11.004  

Author Institution:Methodist Neurological Institute, Houston, TX  Movement Disorders Center, Tampa, FL  Amneal Pharmaceuticals, Bridgewater, NJ  Amneal Pharmaceuticals, Evanston, IL  Amneal Pharmaceuticals, Warren, NJ  

Impact of CREXONT on Parkinson’s Patients’ Motor States Upon Awakening: Analysis of Patient Diary Data

Author:Isaacson, Stuart   Fernandez, Hubert   Kilbane, Camilla   Banisadr, Ghazal   Pitman, Arkadiy   Fisher, Stanley   D'Souza, Richard   

Session Name:P11: Movement Disorders: Therapeutics in Study for Parkinson's Disease  

Topic:Movement Disorders  

Program Number:P11.010  

Author Institution:Parkinson's Dis & Mov Dis Ctr of Boca Raton, Boca Raton, FL  Center for Neurological Restoration, Cleveland Clinic, Cleveland, OH  University Hospitals Cleveland Medical Center, Cleveland, OH  Amneal Pharmaceuticals, Evanston, IL  Amneal Pharmaceuticals, Warren, NJ  

Opicapone Improved Parkinson’s Disease-related Sleep Disturbances: Findings from the OASIS Study

Author:Gago, Miguel   Costa, Raquel   Fonseca, Miguel   Almeida, Joana   Brigas, Helena   Banisadr, Ghazal   Rocha, José-Francisco   Holenz, Joerg   Ferreira, Joaquim   

Session Name:P11: Movement Disorders: Therapeutics in Study for Parkinson's Disease  

Topic:Movement Disorders  

Program Number:P11.020  

Author Institution:Department of Neurology, ULS Alto Ave, Hospital da Senhora da Oliveira  Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho  CNS - Campus Neurológico, Guimarães, Portugal  BIAL – Portela & Ca S.A., CORONADO (S. Romão E S. Mamede, Portugal  Amneal Pharmaceuticals, Evanston, IL  IMM Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa  CNS-Campus Neurológico, Instituto De Medicin, Portugal